MAJESTY, the first global Phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years –– Up to 30% of people with membranous nephropathy progress to ...

MAJESTY, the first global phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years ; Up to 30% of people with membranous neph ...

Supporters packed The Crab Barn early Friday morning for a watch party cheering on Olympic skeleton athlete Mystique Ro as she competed on the world stage. The event began just after 10 a.m., with the ...

Mystique Ro is about to make her Winter Olympics debut. The 31-year-old, who was born in Oceanside, California and raised in Nokesville, Virginia, is looking to make her mark when she takes the stage ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in people with progressive and treatment-resistant systemic sclerosis (SSc), ...

Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon Therapeutics in 2023, hit the primary endpoint in a phase 2 trial for discoid lupus ...

Ro Hutchinson is set to announce a big life change in new Hollyoaks scenes — though one character isn't too pleased. The plot marks the first significant storyline for the character, who is trans, ...

Rep. Ro Khanna (D-Calif.) on Monday slammed the Department of Justice’s assessment that there will be no further investigation into people associated with convicted sex offender Jeffrey Epstein, ...

Mystique Ro used to dream of being on the U.S. Olympic track team. Now, she's a U.S. medal hope in skeleton. Robert Michael / dpa via Associated Press To hear Mystique Ro talk about the first time she ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Subcutaneous anifrolumab improved over placebo in BICLA ...